Gabapentin analogues for fibromy algia and other disorders
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- WARNER-LAMBERT CO
- Publication Date
- 2006-01-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the use of α2δ ligands in the treatment of fibromyalgia and other central nervous system disorders. Background technique
[0002] Fibromyalgia (FM) is a chronic syndrome characterized by protracted pain, nonrestorative sleep, mood disturbance, and fatigue. The main symptoms of fibromyalgia include pain, sleep, mood disturbance, and fatigue. The syndromes associated with fibromyalgia include irritable bowel syndrome and migraine. The success of treating fibromyalgia with single agents has been limited and clinical trial results have been disappointing. Based on the current understanding of the mechanisms and pathways involved in fibromyalgia, it is believed that there is a need for multiple drugs that target key symptoms such as pain, sleep disturbance, mood disturbance, and fatigue. Patients with fibromyalgia are often sensitive to drug side effects, a feature that may be related to the pathology of the condition (Ba...